Exercise Intervention as a Therapy in Patients with Diabetes Mellitus and Sarcopenia: A Meta-Analysis

[1] Nishimura T(2020)Adverse effects of the coexistence of locomotive syndrome and sarcopenia on the walking ability and performance of activities of daily living in Japanese elderly females: a cross-sectional study J Phys Ther Sci 32 227-232

[2] Imai A(2010)An overview of sarcopenia: facts and numbers on prevalence and clinical impact J Cach Sarcop Muscle. 1 129-33

[3] Fujimoto M(2019)Sarcopenia, frailty and their prevention by exercise Free Radic Biol Med 20 42-49

[4] Kurihara T(2016)Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia’s ageing population? Med J Aust 205 329-333

[5] Kagawa K(2016)Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly Sci Rep 6 38937-22

[6] Nagata T(2020)Sarcopenia, nutritional status and type 2 diabetes mellitus: a cross-sectional study in a group of Mexican women residing in a nursing home Nutr Diet. 77 515-74

[7] Sanada K(2015)Sarcopenia as the biological substrate of physical frailty Clin Geriat Med. 31 367-605

[8] Von Haehling S(2011)Cochrane statistical methods group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 18 d5928-31

[9] Morley JE(2010)Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 25 603-5

[10] Anker SD(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration J Clin Epidemiol. 6 e1000100-87

[1] Nishimura T(2020)Adverse effects of the coexistence of locomotive syndrome and sarcopenia on the walking ability and performance of activities of daily living in Japanese elderly females: a cross-sectional study J Phys Ther Sci 32 227-232

[2] Imai A(2010)An overview of sarcopenia: facts and numbers on prevalence and clinical impact J Cach Sarcop Muscle. 1 129-33

[3] Fujimoto M(2019)Sarcopenia, frailty and their prevention by exercise Free Radic Biol Med 20 42-49

[4] Kurihara T(2016)Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia’s ageing population? Med J Aust 205 329-333

[5] Kagawa K(2016)Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly Sci Rep 6 38937-22

[6] Nagata T(2020)Sarcopenia, nutritional status and type 2 diabetes mellitus: a cross-sectional study in a group of Mexican women residing in a nursing home Nutr Diet. 77 515-74

[7] Sanada K(2015)Sarcopenia as the biological substrate of physical frailty Clin Geriat Med. 31 367-605

[8] Von Haehling S(2011)Cochrane statistical methods group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 18 d5928-31

[9] Morley JE(2010)Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 25 603-5

[10] Anker SD(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration J Clin Epidemiol. 6 e1000100-87